Roadside Drug Testing Devices Market By Sample Type (Saliva, Breath, Others), By Substance (Drugs, Alcohol), By End User (Highway Police, Drug Enforcement Agencies): Global Opportunity Analysis and Industry Forecast, 2021-2031
The roadside drug testing devices market was valued at 421.76 million in 2021, and is projected to reach $707.28 million by 2031 registering a CAGR of 5.3%from 2022 to 2031
The roadside drug testing refers to looking for traces of drugs in the body using samples of urine, blood, sweat or breath. Passing of drug testing or drug screening tests means that the drug might not be present in the body anymore or presence is in very small amount. This type of roadside drug testing is conducted to ensure safety of the motor vehicle drivers, as influence of drugs and/or alcohol hinders with clear sight and quick mental function.
Roadside drug testing is often done either by taking sample saliva or breath of the vehicle driver. The device, which is known as breathalyzer, uses deep-lung breath of the tester and thus, detects presence of alcohol in blood. Saliva is more effective at identifying most recent drug usage. However, saliva-based drug testing has the drawback that it is neither Food and Drug Administration approved for use with Department of Telecommunications nor federally mandated drug testing.
Increase in prevalence of drink and drive all over the globe, propel the growth of the roadside drug testing devices market. For instance, according to a report by the National Institute on Alcohol Abuse and Alcoholism in 2019, 10,142 people lost their lives as a result of drunk driving.
The roadside drug testing devices market is segmented on the basis of sample type, substance type, and end user. As per sample type, the market is divided into saliva, breath, and others.
By end user, the market is divided into highway police and drug enforcement agencies. On the basis of region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include, AK GlobalTech Corp., Abbott Laboratories, Drager, Alcohol Countermeasure Systems Corp., Cannabix Technologies Inc., Intelligent Fingerprinting, Lifeloc Technologies, Inc., Oranoxis Inc., Thermo Fisher Scientific, Inc., and UriTox LLC.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the roadside drug testing devices market analysis from 2021 to 2031 to identify the prevailing roadside drug testing devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the roadside drug testing devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global roadside drug testing devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Sample Type
Saliva
Breath
Others
By Substance
Drugs
Alcohol
By End User
Highway Police
Drug Enforcement Agencies
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Dräger
Alcohol Countermeasure Systems Corp.
AK GlobalTech Corporation
Cannabix Technologies Inc.
Intelligent Fingerprinting
Lifeloc Technologies, Inc.
Oranoxis Inc.
Thermo Fisher Scientific, Inc.
UriTox LLC.
Abbott Laboratories
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Saliva
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Breath
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4 Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- CHAPTER 5: ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Drugs
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Alcohol
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- CHAPTER 6: ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Highway Police
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market share analysis by country
- 6.3 Drug Enforcement Agencies
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market share analysis by country
- CHAPTER 7: ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Sample Type
- 7.2.3 North America Market size and forecast, by Substance
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Key market trends, growth factors and opportunities
- 7.2.5.1.2 Market size and forecast, by Sample Type
- 7.2.5.1.3 Market size and forecast, by Substance
- 7.2.5.1.4 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Key market trends, growth factors and opportunities
- 7.2.5.2.2 Market size and forecast, by Sample Type
- 7.2.5.2.3 Market size and forecast, by Substance
- 7.2.5.2.4 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Key market trends, growth factors and opportunities
- 7.2.5.3.2 Market size and forecast, by Sample Type
- 7.2.5.3.3 Market size and forecast, by Substance
- 7.2.5.3.4 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Sample Type
- 7.3.3 Europe Market size and forecast, by Substance
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Key market trends, growth factors and opportunities
- 7.3.5.1.2 Market size and forecast, by Sample Type
- 7.3.5.1.3 Market size and forecast, by Substance
- 7.3.5.1.4 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Key market trends, growth factors and opportunities
- 7.3.5.2.2 Market size and forecast, by Sample Type
- 7.3.5.2.3 Market size and forecast, by Substance
- 7.3.5.2.4 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Key market trends, growth factors and opportunities
- 7.3.5.3.2 Market size and forecast, by Sample Type
- 7.3.5.3.3 Market size and forecast, by Substance
- 7.3.5.3.4 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Key market trends, growth factors and opportunities
- 7.3.5.4.2 Market size and forecast, by Sample Type
- 7.3.5.4.3 Market size and forecast, by Substance
- 7.3.5.4.4 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Key market trends, growth factors and opportunities
- 7.3.5.5.2 Market size and forecast, by Sample Type
- 7.3.5.5.3 Market size and forecast, by Substance
- 7.3.5.5.4 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Key market trends, growth factors and opportunities
- 7.3.5.6.2 Market size and forecast, by Sample Type
- 7.3.5.6.3 Market size and forecast, by Substance
- 7.3.5.6.4 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Sample Type
- 7.4.3 Asia-Pacific Market size and forecast, by Substance
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Key market trends, growth factors and opportunities
- 7.4.5.1.2 Market size and forecast, by Sample Type
- 7.4.5.1.3 Market size and forecast, by Substance
- 7.4.5.1.4 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Key market trends, growth factors and opportunities
- 7.4.5.2.2 Market size and forecast, by Sample Type
- 7.4.5.2.3 Market size and forecast, by Substance
- 7.4.5.2.4 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Key market trends, growth factors and opportunities
- 7.4.5.3.2 Market size and forecast, by Sample Type
- 7.4.5.3.3 Market size and forecast, by Substance
- 7.4.5.3.4 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Key market trends, growth factors and opportunities
- 7.4.5.4.2 Market size and forecast, by Sample Type
- 7.4.5.4.3 Market size and forecast, by Substance
- 7.4.5.4.4 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Key market trends, growth factors and opportunities
- 7.4.5.5.2 Market size and forecast, by Sample Type
- 7.4.5.5.3 Market size and forecast, by Substance
- 7.4.5.5.4 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Key market trends, growth factors and opportunities
- 7.4.5.6.2 Market size and forecast, by Sample Type
- 7.4.5.6.3 Market size and forecast, by Substance
- 7.4.5.6.4 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Sample Type
- 7.5.3 LAMEA Market size and forecast, by Substance
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Key market trends, growth factors and opportunities
- 7.5.5.1.2 Market size and forecast, by Sample Type
- 7.5.5.1.3 Market size and forecast, by Substance
- 7.5.5.1.4 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Key market trends, growth factors and opportunities
- 7.5.5.2.2 Market size and forecast, by Sample Type
- 7.5.5.2.3 Market size and forecast, by Substance
- 7.5.5.2.4 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Key market trends, growth factors and opportunities
- 7.5.5.3.2 Market size and forecast, by Sample Type
- 7.5.5.3.3 Market size and forecast, by Substance
- 7.5.5.3.4 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Key market trends, growth factors and opportunities
- 7.5.5.4.2 Market size and forecast, by Sample Type
- 7.5.5.4.3 Market size and forecast, by Substance
- 7.5.5.4.4 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Abbott Laboratories
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 AK GlobalTech Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Alcohol Countermeasure Systems Corp.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Cannabix Technologies Inc.
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Dräger
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Intelligent Fingerprinting
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Lifeloc Technologies, Inc.
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Oranoxis Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Thermo Fisher Scientific, Inc.
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 UriTox LLC.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. ROADSIDE DRUG TESTING DEVICES MARKET FOR SALIVA, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. ROADSIDE DRUG TESTING DEVICES MARKET FOR SALIVA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. ROADSIDE DRUG TESTING DEVICES MARKET FOR BREATH, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. ROADSIDE DRUG TESTING DEVICES MARKET FOR BREATH, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. ROADSIDE DRUG TESTING DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. ROADSIDE DRUG TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUGS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. ROADSIDE DRUG TESTING DEVICES MARKET FOR ALCOHOL, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. ROADSIDE DRUG TESTING DEVICES MARKET FOR ALCOHOL, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. ROADSIDE DRUG TESTING DEVICES MARKET FOR HIGHWAY POLICE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. ROADSIDE DRUG TESTING DEVICES MARKET FOR HIGHWAY POLICE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUG ENFORCEMENT AGENCIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUG ENFORCEMENT AGENCIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 70. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 71. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 72. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 73. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 74. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 75. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 76. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 77. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 78. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 79. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 80. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 81. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 82. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 83. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 84. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 85. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 86. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 87. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 88. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 89. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
- TABLE 90. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
- TABLE 91. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
- TABLE 92.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 93.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 94.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 95.ABBOTT LABORATORIES: NET SALES
- TABLE 96.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 97.AK GLOBALTECH CORPORATION: COMPANY SNAPSHOT
- TABLE 98.AK GLOBALTECH CORPORATION: OPERATING SEGMENTS
- TABLE 99.AK GLOBALTECH CORPORATION: PRODUCT PORTFOLIO
- TABLE 100.AK GLOBALTECH CORPORATION: NET SALES
- TABLE 101.AK GLOBALTECH CORPORATION: KEY STRATERGIES
- TABLE 102.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: COMPANY SNAPSHOT
- TABLE 103.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: OPERATING SEGMENTS
- TABLE 104.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: PRODUCT PORTFOLIO
- TABLE 105.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: NET SALES
- TABLE 106.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: KEY STRATERGIES
- TABLE 107.CANNABIX TECHNOLOGIES INC.: COMPANY SNAPSHOT
- TABLE 108.CANNABIX TECHNOLOGIES INC.: OPERATING SEGMENTS
- TABLE 109.CANNABIX TECHNOLOGIES INC.: PRODUCT PORTFOLIO
- TABLE 110.CANNABIX TECHNOLOGIES INC.: NET SALES
- TABLE 111.CANNABIX TECHNOLOGIES INC.: KEY STRATERGIES
- TABLE 112.DRÄGER: COMPANY SNAPSHOT
- TABLE 113.DRÄGER: OPERATING SEGMENTS
- TABLE 114.DRÄGER: PRODUCT PORTFOLIO
- TABLE 115.DRÄGER: NET SALES
- TABLE 116.DRÄGER: KEY STRATERGIES
- TABLE 117.INTELLIGENT FINGERPRINTING: COMPANY SNAPSHOT
- TABLE 118.INTELLIGENT FINGERPRINTING: OPERATING SEGMENTS
- TABLE 119.INTELLIGENT FINGERPRINTING: PRODUCT PORTFOLIO
- TABLE 120.INTELLIGENT FINGERPRINTING: NET SALES
- TABLE 121.INTELLIGENT FINGERPRINTING: KEY STRATERGIES
- TABLE 122.LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 123.LIFELOC TECHNOLOGIES, INC.: OPERATING SEGMENTS
- TABLE 124.LIFELOC TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 125.LIFELOC TECHNOLOGIES, INC.: NET SALES
- TABLE 126.LIFELOC TECHNOLOGIES, INC.: KEY STRATERGIES
- TABLE 127.ORANOXIS INC.: COMPANY SNAPSHOT
- TABLE 128.ORANOXIS INC.: OPERATING SEGMENTS
- TABLE 129.ORANOXIS INC.: PRODUCT PORTFOLIO
- TABLE 130.ORANOXIS INC.: NET SALES
- TABLE 131.ORANOXIS INC.: KEY STRATERGIES
- TABLE 132.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
- TABLE 133.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
- TABLE 134.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
- TABLE 135.THERMO FISHER SCIENTIFIC, INC.: NET SALES
- TABLE 136.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
- TABLE 137.URITOX LLC.: COMPANY SNAPSHOT
- TABLE 138.URITOX LLC.: OPERATING SEGMENTS
- TABLE 139.URITOX LLC.: PRODUCT PORTFOLIO
- TABLE 140.URITOX LLC.: NET SALES
- TABLE 141.URITOX LLC.: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.ROADSIDE DRUG TESTING DEVICES MARKET SEGMENTATION
- FIGURE 2.ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031
- FIGURE 3.ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.ROADSIDE DRUG TESTING DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.ROADSIDE DRUG TESTING DEVICES MARKET,BY SAMPLE TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SALIVA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BREATH ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHERS ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 16.ROADSIDE DRUG TESTING DEVICES MARKET,BY SUBSTANCE,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DRUGS ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF ALCOHOL ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 19.ROADSIDE DRUG TESTING DEVICES MARKET,BY END USER,2021(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HIGHWAY POLICE ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DRUG ENFORCEMENT AGENCIES ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031(%)
- FIGURE 22.ROADSIDE DRUG TESTING DEVICES MARKET BY REGION,2021
- FIGURE 23.U.S. ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 24.CANADA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 25.MEXICO ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 26.GERMANY ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 27.FRANCE ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 28.UK ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 29.ITALY ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 30.SPAIN ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 31.REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 32.JAPAN ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 33.CHINA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 34.AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 35.INDIA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 36.SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 37.REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 38.BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 39.SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 40.SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 41.REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET,2021-2031($MILLION)
- FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 46.COMPETITIVE DASHBOARD
- FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 48.ABBOTT LABORATORIES.: NET SALES ($MILLION)
- FIGURE 49.AK GLOBALTECH CORPORATION.: NET SALES ($MILLION)
- FIGURE 50.ALCOHOL COUNTERMEASURE SYSTEMS CORP..: NET SALES ($MILLION)
- FIGURE 51.CANNABIX TECHNOLOGIES INC..: NET SALES ($MILLION)
- FIGURE 52.DRÄGER.: NET SALES ($MILLION)
- FIGURE 53.INTELLIGENT FINGERPRINTING.: NET SALES ($MILLION)
- FIGURE 54.LIFELOC TECHNOLOGIES, INC..: NET SALES ($MILLION)
- FIGURE 55.ORANOXIS INC..: NET SALES ($MILLION)
- FIGURE 56.THERMO FISHER SCIENTIFIC, INC..: NET SALES ($MILLION)
- FIGURE 57.URITOX LLC..: NET SALES ($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook